Entero Therapeutics
ENTO2.9900.00% ( 0.000 )
Entero Therapeutics (ENTO)
Entero Therapeutics, Inc. designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 2.990
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 5.840
- Volume Ratio
- 0.00
- Turnover Ratio
- --
News
- prnewswire · Mar 23 at 06:30 AM
07:30 ETEndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis
- Tip Ranks · Dec 4, 2025 at 04:49 PM
GridAI Technologies Announces Board Changes and Rebranding
- rttnews · Nov 30, 2025 at 09:32 PM
Biotech Momentum Builds In After-Hours Trading As BioAtla, Entero, And Sonnet Climb
- benzinga_article · Nov 20, 2025 at 10:53 AM
Entero Therapeutics shares are trading lower. The company reported Q3 financial results.
- Earnings Watch · Nov 19, 2025 at 04:15 PM
Entero Therapeutics | 10-Q: FY2025 Q3 Revenue: USD 0
- Tip Ranks · Nov 19, 2025 at 08:00 AM
NASDAQ: ENTO's Grid AI Strikes Texas Hyperscale Deal as its $50M Industrial Software Platform Enters the AI Race
